Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Theodorescu

Showing results (31-40 of 275) with videos related to

Pageof 28
Sort By:
Scandinavian Journal of Urology and Nephrology|May 11, 2002
Adrenal tumor with caval extension--case report and review of the literatureJohn P Chesson, Dan Theodorescu
Future Oncology (London, England)|June 17, 2011
Genetic testing for metastasis: potential for improved cancer treatmentDara L Aisner, Dan Theodorescu
World Journal of Urology|March 25, 2006
Status of robotic cystectomy in 2005Nicole L Miller, Dan Theodorescu
Nature Reviews. Urology|November 15, 2017
Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapyKenneth M Felsenstein, Dan Theodorescu
European Urology|May 30, 2012
Words of wisdom. Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 statusThomas W Flaig, Dan Theodorescu
Oncoscience|January 21, 2017
CD44: A metastasis driver and therapeutic targetJoseph L Sottnik, Dan Theodorescu
European Urology Focus|March 27, 2022
Using Cell Lines To Guide Neoadjuvant Therapy in Bladder Cancer: COXEN and SWOG S1314Garrett M Dancik, Dan Theodorescu
Journal of Cellular Immunology|January 27, 2022
The Potential of Combination Therapies and Patient Stratification to Improve CCR2 Inhibition TherapeuticsJason E Duex, Dan Theodorescu
Oncology (Williston Park, N.Y.)|October 7, 2010
Rare bladder tumors: caveat emptorShandra S Wilson, Dan Theodorescu
The Canadian Journal of Urology|March 23, 2005
Surgery or radiation: what is the optimal management for locally advanced prostate cancer?Sophie G Fletcher, Dan Theodorescu
Pageof 28

Showing results (31-40 of 275) with videos related to

Sort By:
Pageof 28
Scandinavian Journal of Urology and Nephrology|May 11, 2002
Adrenal tumor with caval extension--case report and review of the literatureJohn P Chesson, Dan Theodorescu
Future Oncology (London, England)|June 17, 2011
Genetic testing for metastasis: potential for improved cancer treatmentDara L Aisner, Dan Theodorescu
World Journal of Urology|March 25, 2006
Status of robotic cystectomy in 2005Nicole L Miller, Dan Theodorescu
Nature Reviews. Urology|November 15, 2017
Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapyKenneth M Felsenstein, Dan Theodorescu
European Urology|May 30, 2012
Words of wisdom. Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 statusThomas W Flaig, Dan Theodorescu
Oncoscience|January 21, 2017
CD44: A metastasis driver and therapeutic targetJoseph L Sottnik, Dan Theodorescu
European Urology Focus|March 27, 2022
Using Cell Lines To Guide Neoadjuvant Therapy in Bladder Cancer: COXEN and SWOG S1314Garrett M Dancik, Dan Theodorescu
Journal of Cellular Immunology|January 27, 2022
The Potential of Combination Therapies and Patient Stratification to Improve CCR2 Inhibition TherapeuticsJason E Duex, Dan Theodorescu
Oncology (Williston Park, N.Y.)|October 7, 2010
Rare bladder tumors: caveat emptorShandra S Wilson, Dan Theodorescu
The Canadian Journal of Urology|March 23, 2005
Surgery or radiation: what is the optimal management for locally advanced prostate cancer?Sophie G Fletcher, Dan Theodorescu
Pageof 28